These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16687059)

  • 1. Uric acid in multiple sclerosis.
    Koch M; De Keyser J
    Neurol Res; 2006 Apr; 28(3):316-9. PubMed ID: 16687059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum uric acid levels and leukocyte nitric oxide production in multiple sclerosis patients outside relapses.
    Mostert JP; Ramsaransing GS; Heersema DJ; Heerings M; Wilczak N; De Keyser J
    J Neurol Sci; 2005 Apr; 231(1-2):41-4. PubMed ID: 15792819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of uric acid in protection against peroxynitrite-mediated pathology.
    Scott GS; Hooper DC
    Med Hypotheses; 2001 Jan; 56(1):95-100. PubMed ID: 11133262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid.
    Squadrito GL; Cueto R; Splenser AE; Valavanidis A; Zhang H; Uppu RM; Pryor WA
    Arch Biochem Biophys; 2000 Apr; 376(2):333-7. PubMed ID: 10775420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Uric acid and multiple sclerosis].
    Mattle HP; Lienert C; Greeve I
    Ther Umsch; 2004 Sep; 61(9):553-5. PubMed ID: 15493114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis.
    Hooper DC; Spitsin S; Kean RB; Champion JM; Dickson GM; Chaudhry I; Koprowski H
    Proc Natl Acad Sci U S A; 1998 Jan; 95(2):675-80. PubMed ID: 9435251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric acid: a novel treatment strategy for multiple sclerosis.
    Mousavizadeh K; Dehpour AR; Minagar A; Ghafourifar P
    Trends Pharmacol Sci; 2003 Nov; 24(11):563-4; author reply 564-5. PubMed ID: 14607077
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors.
    Scott GS; Spitsin SV; Kean RB; Mikheeva T; Koprowski H; Hooper DC
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16303-8. PubMed ID: 12451183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Uric acid as a scavenger in oxidative stress].
    Staub M
    Orv Hetil; 1999 Feb; 140(6):275-9. PubMed ID: 10071505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum uric acid and multiple sclerosis.
    Sotgiu S; Pugliatti M; Sanna A; Sotgiu A; Fois ML; Arru G; Rosati G
    Neurol Sci; 2002 Oct; 23(4):183-8. PubMed ID: 12536287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis.
    Hooper DC; Bagasra O; Marini JC; Zborek A; Ohnishi ST; Kean R; Champion JM; Sarker AB; Bobroski L; Farber JL; Akaike T; Maeda H; Koprowski H
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2528-33. PubMed ID: 9122229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels.
    Calabrese V; Scapagnini G; Ravagna A; Bella R; Foresti R; Bates TE; Giuffrida Stella AM; Pennisi G
    J Neurosci Res; 2002 Nov; 70(4):580-7. PubMed ID: 12404512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of uric acid in multiple sclerosis.
    Spitsin S; Koprowski H
    Curr Top Microbiol Immunol; 2008; 318():325-42. PubMed ID: 18219824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum uric acid and multiple sclerosis.
    Rentzos M; Nikolaou C; Anagnostouli M; Rombos A; Tsakanikas K; Economou M; Dimitrakopoulos A; Karouli M; Vassilopoulos D
    Clin Neurol Neurosurg; 2006 Sep; 108(6):527-31. PubMed ID: 16202511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis.
    Dujmovic I; Pekmezovic T; Obrenovic R; Nikolić A; Spasic M; Mostarica Stojkovic M; Drulovic J
    Clin Chem Lab Med; 2009; 47(7):848-53. PubMed ID: 19496733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum uric acid levels in patients with multiple sclerosis: a meta-analysis.
    Liu B; Shen Y; Xiao K; Tang Y; Cen L; Wei J
    Neurol Res; 2012 Mar; 34(2):163-71. PubMed ID: 22333889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose methylprednisolone therapy in multiple sclerosis increases serum uric acid levels.
    Toncev G; Milicic B; Toncev S; Samardzic G
    Clin Chem Lab Med; 2002 May; 40(5):505-8. PubMed ID: 12113297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase.
    Kuzkaya N; Weissmann N; Harrison DG; Dikalov S
    Biochem Pharmacol; 2005 Aug; 70(3):343-54. PubMed ID: 15963955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidants in multiple sclerosis: do they have a role in therapy?
    Carlson NG; Rose JW
    CNS Drugs; 2006; 20(6):433-41. PubMed ID: 16734496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxynitrite formation within the central nervous system in active multiple sclerosis.
    Cross AH; Manning PT; Keeling RM; Schmidt RE; Misko TP
    J Neuroimmunol; 1998 Aug; 88(1-2):45-56. PubMed ID: 9688323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.